Perspectives in educating molecular pathologists on liquid biopsy: Toward integrative, equitable, and decentralized precision oncology
Year: 2025
Type: article
Abstract: Liquid biopsy has transformed molecular oncology by enabling noninvasive, real-time monitoring of cancer progression, treatment responses, and detection of minimal residual disease. Despite technological advances, educational gaps, regarding standardized, comprehensive training for molecular pathologists, remain. To address these, a new educational program, the European Masters in Molecular Pathology (EMMP) developed a dedicated educational module aimed at providing pathologists with specialized competencies in liquid biopsy. In this perspective, we discuss how embedding liquid biopsy training within the integrative pathology framework, linking molecular diagnostics, histopathological findings, and clinical context, enhances diagnostic accuracy and therapeutic decision-making in the clinic. Furthermore, we emphasize the importance of decentralizing liquid biopsy expertise to local pathology units, reducing dependency on external commercial platforms, ensuring data sovereignty, and enabling rapid, cost-effective diagnostics. Finally, integrating health policy and ethical considerations within liquid biopsy education prepares future molecular pathologists to engage meaningfully in shaping policy frameworks that support equitable and sustainable clinical implementation of precision oncology. In summary, we propose the EMMP module as a comprehensive educational strategy for training molecular pathologists in the latest liquid biopsy technologies and advancements.
Source: Molecular Oncology
Institutions: Université Côte d'Azur, Centre Hospitalier Universitaire de Nice, University of Naples Federico II, Centre National de la Recherche Scientifique, Université de Montpellier, Institut de Recherche pour le Développement, Aarhus University, Aarhus University Hospital, The University of Texas MD Anderson Cancer Center, Institut universitaire du cancer de Toulouse Oncopole, Medical University of Graz, University Medical Center Hamburg-Eppendorf
Language: English
Subfield: Cancer Research
Domain: Life Sciences
Open Access status: gold
Estimated APC paid: $4,300
Funder: Agence Nationale de la Recherche
Awards: G1190173965, G1460875222
OpenAlex ID: W4416201572
